Say goodbye to brain scans! How blood tests are set to revolutionize Alzheimer’s detection
A groundbreaking study by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has revealed that certain blood tests are now accurate enough ... Read More
Eisai invests $15m in C₂N Diagnostics to advance Alzheimer’s disease diagnostics
In a significant move for the field of brain health diagnostics, C₂N Diagnostics, LLC, a pioneer in developing advanced diagnostic solutions for Alzheimer's disease, has ... Read More